OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 9 citing articles:

COVID-19 and Respiratory Virus Co-Infections: A Systematic Review of the Literature
Helena C. Maltezou, Amalia Papanikolopoulou, Sofia Vassiliu, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 865-865
Open Access | Times Cited: 44

Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant
G Pastore, Jacopo Polvere, Fabio Fiorino, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 432-444
Open Access | Times Cited: 5

Neutralizing and binding antibody dynamics following primary and booster COVID-19 vaccination among healthcare workers
Irmak Güzel, Gamze ÖZTÜRK, Özgür Appak, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access

Effectiveness of full (booster) COVID-19 vaccination against severe outcomes and work absenteeism in hospitalized patients with COVID-19 during the Delta and Omicron waves in Greece
Helena C. Maltezou, Dimitrios Basoulis, Konstantinos Bonelis, et al.
Vaccine (2023) Vol. 41, Iss. 14, pp. 2343-2348
Open Access | Times Cited: 11

Novel Competitive ELISA Utilizing Trimeric Spike Protein of SARS-CoV-2, Could Identify More Than RBD-RBM Specific Neutralizing Antibodies in Hybrid Sera
Petros Eliadis, Annie Mais, Alexandros Papazisis, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 914-914
Open Access | Times Cited: 2

Timing of last COVID-19 vaccine dose and SARS-CoV-2 breakthrough infections in fully (boosted) vaccinated healthcare personnel
Helena C. Maltezou, Maria N. Gamaletsou, Theodoros V. Giannouchos, et al.
Journal of Hospital Infection (2022) Vol. 132, pp. 46-51
Open Access | Times Cited: 7

SARS-CoV-2 S-RBD IgG & Neutralizing antibodies among different categories of health care workers post third dose BNT162b2 mRNA COVID-19 vaccine
Wan Muhammad Azfar Wan Shuaib, Izzatul Aliaa Badaruddin, Munirah Md Mansor, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access | Times Cited: 2

Long-term antibody response after the third dose of inactivated SARS-CoV-2 vaccine in MASLD patients
Jin Cui, Lianbang Wang, Armin Ghavamian, et al.
BMC Gastroenterology (2024) Vol. 24, Iss. 1
Open Access

Comparative study of anti-SARS-CoV-2 receptor-binding domain total antibody titer before and after heterologous booster with mRNA-based COVID-19 vaccine
Qatrunnada Kamil, Widia Putri, Arianisah P. Ayulinda, et al.
Narra J (2024) Vol. 4, Iss. 3, pp. e788-e788
Closed Access

Page 1

Scroll to top